These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5433513)

  • 21. [Treatment of pemphigus vulgaris and non-acantholytic pemphigus with methotrexate (review of the literature)].
    Kreĭnin VM
    Vestn Dermatol Venerol; 1971 Feb; 45(2):8-14. PubMed ID: 5563606
    [No Abstract]   [Full Text] [Related]  

  • 22. [Various cases of pemphigus (treatment with corticosteroids + immunosuppressive agents)].
    Rocha GL; Miranda O; Ciuffo D; Mesquita A; Olivi WR; Balassiano E; Szrman WH
    Hospital (Rio J); 1969 Dec; 76(6):2099-106. PubMed ID: 5309259
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pemphigus vulgaris (current aspects of its etiology, pathogenesis, clinical picture, diagnosis and treatment)].
    Torsuev NA; Romanenko VN
    Vestn Dermatol Venerol; 1972 Sep; 46(9):7-11. PubMed ID: 4651908
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current pharmacotherapy of pemphigus].
    Turkevich IuM
    Farm Zh; 1977; 32(1):44-8. PubMed ID: 324796
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of pemphigus vulgaris with methotrexate.
    Lever WF; Goldberg HS
    Arch Dermatol; 1969 Jul; 100(1):70-8. PubMed ID: 5822360
    [No Abstract]   [Full Text] [Related]  

  • 26. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined drug treatment of pemphigus using corticosteroids and methotrexate].
    Ruszczak Z; Bienias L; Bednarowicz G; Prószyńska-Kuczyńska W
    Przegl Dermatol; 1973; 60(5):653-7. PubMed ID: 4772495
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies in bullous diseases: treatment of pemphigus vulgaris with methotrexate, two patients (one with concurrent myasthenia gravis).
    Peck SM; Osserman KE
    J Mt Sinai Hosp N Y; 1969; 36(1):71-6. PubMed ID: 5249498
    [No Abstract]   [Full Text] [Related]  

  • 29. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemphigus vulgaris successfully treated with cyclophosphamide.
    Ebringer A; Mackay IR
    Ann Intern Med; 1969 Jul; 71(1):125-7. PubMed ID: 5791089
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Storb R; Thomas ED
    N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 33. Anterior segment recurrence of acute myelogenous leukemia: treatment with subconjunctival injections of methotrexate and triamcinolone acetonide.
    Katz SE; Wade NK; Anderson DP; Rootman J
    Can J Ophthalmol; 1997 Jun; 32(4):265-7. PubMed ID: 9199837
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis and management of autoimmune diseases of the skin.
    Sams WM
    Postgrad Med; 1972 Nov; 52(5):171-5. PubMed ID: 5080949
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience in treating pemphigus with corticosteroids and methotrexate].
    Romanenko GF; Verbenko EV; Ezhov NIa
    Vestn Dermatol Venerol; 1973 Mar; 47(3):61-4. PubMed ID: 4730102
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine.
    Mobini N; Padilla T; Ahmed AR
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):264-6. PubMed ID: 9039184
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of pemphigus with corticosteroids and methotrexate (literature review)].
    Baliavicieni GR
    Vestn Dermatol Venerol; 1976 Oct; (10):45-8. PubMed ID: 1014817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunosuppressive agents and bullous diseases].
    Beurey J; Weber M; Vadot J; Touret D
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):384-9. PubMed ID: 5510732
    [No Abstract]   [Full Text] [Related]  

  • 39. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and treatment of pemphigus in Iran.
    Chams-Davatchi C
    Dermatol Clin; 2011 Oct; 29(4):681-3. PubMed ID: 21925018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.